Grupo de Investigación en Neuropsicofarmacología

• Brocos-Mosquera I, Gabilondo AM, Diez-Alarcia R, Muguruza C, Erdozain AM, Meana JJ, Callado LF.  α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects European Neuropsychopharmacology,  2021;  52,  3 - 11
• Brocos-Mosquera I, Gabilondo AM, Meana JJ, Callado LF, Erdozain AM.  Spinophilin expression in postmortem prefrontal cortex of schizophrenic subjects: Effects of antipsychotic treatment European Neuropsychopharmacology,  2021;  42,  12 - 21
• Brocos-Mosquera I, Miranda-Azpiazu P, Muguruza C, Corzo-Monje V, Morentin B, Meana JJ, Callado LF, Rivero G.  Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment Translational Psychiatry,  2021;  11(1):643
• Costas-Insua C, Moreno E, Maroto IB, Ruiz-Calvo A, Bajo-Grañeras R, Martín- Gutiérrez D, Diez-Alarcia R, Vilaró MT, Cortés R, García-Font N, Martín R, Espina M, Botta J, Ginés S, McCormick PJ, Sánchez-Prieto J, Galve-Roperh I, Mengod G, Urigüen L, Marsicano G, Bellocchio L, Canela EI, Casadó V, Rodríguez- Crespo I, Guzmán M.  Identification of BiP as a CB 1 Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse Brain Journal of Neuroscience,  2021;  41(38),  7924 - 7941
• Diez-Alarcia R, Muguruza C, Rivero G, García-Bea A, Gómez-Vallejo V, Callado LF, Llop J, Martín A, Meana JJ.  Opposite alterations of 5-HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile Translational Psychiatry,  2021;  11(1):302
• Diez-Alarcia R, Odagaki Y, Miranda-Azpiazu P, Gabilondo AM, Meana JJ, Muneta- Arrate I.  Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTPγS binding assays combined with immunoprecipitation Pharmacological Reports,  2021;  73(4):1203
• Egusquiza I, Munarriz-Cuezva E, Segarra R, González-Maeso J, Callado LF, Meana JJ, Diez-Alarcia R.  Characterization of dopamine D2 receptor coupling to G proteins in postmortem brain of subjects with schizophrenia Pharmacological Reports,  2021;  73(4),  1136 - 1146
• García-Salvador A, Quintela S, Horrillo I, Aróstegui S, Bilbao A, Villaran MC, Meana JJ, Goñi F.  Enfermedades mentales y nutrición saludable. Nuevas alternativas para su tratamiento Revista Española de Nutrición Comunitaria,  2021;  27,  70 - 81
• Hurel I, Muguruza C, Redon B, Marsicano G, Chaouloff F.  Cannabis and exercise: Effects of Δ9-tetrahydrocannabinol on preference and motivation for wheel-running in mice Progress in Neuro-Psychopharmacology & Biological Psychiatry,  2021;  105:110117
• Ibarra-Lecue I, Diez-Alarcia R, Urigüen L.  Serotonin 2A receptors and cannabinoids Progress in Brain Research,  2021;  259,  135 - 175
• MacDowell KS, Munarriz-Cuezva E, Meana JJ, Leza JC, Ortega JE.  Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways Frontiers in Pharmacology,  2021;  12:682602
• McMullan M, Kelly B, Mihigo HB, Keogh AP, Rodriguez F, Brocos-Mosquera I,García-Bea A, Miranda-Azpiazu P, Callado LF, Rozas I.  Di-aryl guanidinium derivatives: Towards improved α2-Adrenergic affinity and antagonist activity European Journal of Medicinal Chemistry,  2021;  209:112947
• Nuñez-delMoral A, Brocos-Mosquera I, Vialou V, Callado LF, Erdozain AM.  Characterization of hevin (SPARCL1) immunoreactivity in postmortem human brain homogenates Neuroscience,  2021;  467,  91 - 109
• Odagaki Y, Kinoshita M, Meana JJ, Callado LF, García-Sevilla JA.  5-HT 2A receptor- and M 1 muscarinic acetylcholine receptor-mediated activation of Gα q/11 in postmortem dorsolateral prefrontal cortex of opiate addicts Pharmacological Reports,  2021;  73(4),  1155 - 1163
• Odagaki Y, Kinoshita M, Meana JJ, Callado LF, García-Sevilla JA.  5-HT2A receptor-mediated Gαq/11 activation in psychiatric disorders: A postmortem study The World Journal of Biological Psychiatry,  2021;  22(7),  505 - 515
• Odagaki Y, Meana JJ.  Special issue "role of G-proteins and GPCR-mediated signaling in the pathophysiology and treatment of psychiatric disorders" Pharmacological Reports,  2021;  73(4),  967 - 969
• Oliveira da Cruz JF, Ioannidou C, Pagano Zottola AC, Muguruza C, Gomez-Sotres P, Fernandez M, Callado LF, Marsicano G, Busquets-Garcia A.  Sex-dependent pharmacological profiles of the synthetic cannabinoid MMB-Fubinaca Addiction Biology,  2021;  26(3):e12940
• Prischich D, Gomila AMJ, Milla-Navarro S, Sangüesa G, Diez-Alarcia R, Preda B, Matera C, Batlle M, Ramírez L, Giralt E, Hernando J, Guasch E, Meana JJ, de la Villa P, Gorostiza P.  Adrenergic Modulation With Photochromic Ligands Angewandte Chemie International Edition in English,  2021;  60(7),  3625 - 3631
• Ramos-Miguel A, Jones AA, Petyuk VA, Barakauskas VE, Barr AM, Leurgans SE, De Jager PL, Casaletto KB, Schneider JA, Bennett DA, Honer WG.  Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample Acta Neuropathologica,  2021;  141(5),  755 - 770
• Ramos-Miguel A, Sánchez-Blázquez P, García-Sevilla JA.  Effects of Gαi 2 and Gαz protein knockdown on alpha 2A-adrenergic and cannabinoid CB 1 receptor regulation of MEK-ERK and FADD pathways in mouse cerebral cortex Pharmacological Reports,  2021;  73(4),  1122 - 1135